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A  study of the pathological and immunological changes that take 
place in the vicinity of an area of local inflammation may shed some 
light on the general protective mechanism of the body against infec- 
tion.  During the course of lobar pneumonia the pleura, being contigu- 
ous to the lung and sharing, at least in part, in its inflammatory reac- 
tions, offers an opportunity for such a study.  Furthermore, with the 
recognition of the value  of  specific antipneumococcic serum in  the 
treatment of certain types of lobar pneumonia, the problem of whether 
or not such serum reaches the lung and pleura becomes of practical 
importance.  The present work consists, primarily, of the application 
of common bacteriological and immunological methods to a  study of 
pleural fluids from patients with pneumococcic  pneumonia.  The cyto- 
logical features of such fluids as revealed by observations with a supra- 
vital technique are included in a separate communication (1).  It was 
hoped that some correlation between the immunological reactions and 
the fate of the infectious process might be found. 
LITERATURE 
Since Andral (2) and Laennec (3) first demonstrated clinically the existence of ' 
pleural effusions  in lobar pneumonia, much has been written, especially  in French 
literature,  on this  subject.  Netter (4), however, published the first extensive 
study of the bacteriology of purulent pleural effusions and emphasized the fre- 
quency of the pneumococcus  as an etiological agent.  He showed that each kind 
of organism imparted to the fluid characteristics which were  specific  for the par- 
* This study was aided, in part, by the William W. Wellington Fund of the 
Harvard Medical School. 
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ticular organism involved.  From 6 of the 109 fluids that this author studied, no 
organisms could be recovered either by cultural methods or by animal inocula- 
tions, using mice, rabbits, and guinea pigs.  Pneumococci had previously been 
cultured from purulent pleural exud~tes by Friedl~nder (5), Netter (6), and Fr~nkel 
(7).  More recently, Locke (8) collected the bacteriological findings in 478 cases of 
acute empyema, differentiating the various types among the pneumococci.  The 
frequency of the pneumococcic etiology and the large predominance of Type I 
among the various types was dearly demonstrated. 
Siems (9) quoted a case from Griffon (10) in which agglutination of pneumococci 
was demonstrated in a pneumonic pleural fluid by growing the organisms in it. 
Siems believed that the pneumococcic etiology of postpneumonic effusions could 
be demonstrated not only by culture but also by serological  methods applied to 
the blood serum and to the fluid.  In one instance he demonstrated that a pleural 
fluid had the power to agglutinate the patient's own strain of pneumococcus when 
it failed to agglutinate the laboratory strain.  Cole (11) showed that empyema 
fluids contained no protective substances or agglutinins but that they inhibited 
the protective properties of antipneumococcic sera specifically.  Floyd (12) ob- 
tained "positive precipitin tests" with empyema fluids and noted phagocytosis of 
pneumococci by the cells in these fluids. 
Duyck (13) found fluid containing pneumococci in the pleural cavity of almost 
every one of his cases during the acute stage of lobar pneumonia, especially in the 
presence of septicemia.  In the latter type of case he found large numbers of 
organisms in the fluid.  In spite of this fact, these fluids, when injected fresh, not 
only failed to kill mice but were capable of protecting them against lethal doses of 
pneumococci.  This protection he attributed to leucocytic ferments.  He treated 
cases by removing this fluid and injecting it into the same patient subcutaneously. 
Curphy and Baruch (14) have utilized a similar principle in ~mmunizing horses for 
the production of antipneumococcic sera. 
Pepper (15) demonstrated agglutinins for B. ~yphosus in a pleural effusion accom- 
panying typhoid fever.  The  agglutinin  titer in the fluid was 1:800 and in the 
blood  serum  1:1000.  Courmont  (quoted  by  LeDamany  (16))  demonstrated 
agglutination of tubercle hacilli by pleural fluid, but the method was thought by 
LeDamany not to be infallible.  Many other authors have demonstrated antigen 
and antibodies in tuberculous pleural effusions  (17). 
General immunological characteristics of exudates and transudates have been 
studied  by a  number of workers, some of whom examined pneumonic pleural 
fluids.  Hemolysins and complement have been found in  exudates but  not  in 
transudates (18), and the cell-free exudates have been shown to be bactericidal for 
many organisms, including the pneumococcus (19). 
Numerous workers have made studies of absorption from the pleura] cavity. 
The literature, however, on the passage of immune substances from the blood into 
the pleural cavity or other closed cavities is scant.  The most significant  observa- 
tions have been made on the cerebrospinal fluid in animals.  Mort (20) found that • rAXWELL  ~INLAm~  171 
most drugs and tetanus toxin do not pass from the blood into the cerebrospinal 
fluid, whereas materials injected into the spinal canal appear rapidly in the blood. 
Flexner and his coworkers (21) were unable to detect neutralizing substances  for 
the virus of poliomyelitis in the cerebrospinal fluid of actively jmmlm{md monkeys. 
They also failed to demonstrate agglutinins for meningococci in the fluid of actively 
or passively immunized normal rabbits.  If, however, they produced an  aseptic 
meningitis by injecting saline or normal horse serum into the subarachnoid space, 
they could demonstrate these antibodies.  Freund  (22)  found that the cerebro- 
spinal fluid of animals ~rnmunized with killed typhoid bacilli contains agglutinins 
for these organisms but the titer is very low compared to that of the blood serum. 
Normal animals  passively immunized  by the  intravenous  injection  of typhoid 
immune serum were also shown to have typhoid agglutinins in their cerebrospinal 
fluid after a lapse of several hours.  He explained the negative results previously 
mentioned by the low titer of antibody in the fluid. 
Menkin reviewed the literature  on the dissemination  of  substances from the 
site of injection (23) and showed that foreign protein introduced in the circulating 
blood of a rabbit accumulates in an inflamed area in greater concentration than in 
normal tissues (24). 
Materials  and  Methods 
31 pleural fluids from 19 patients with typical lobar pneumonia were studied, and 
4 fluids from 3 patients with other diseases were studied for controls.  A pneumo- 
coccus was obtained in each of the former cases from the sputum or blood culture 
or both.  Type I pneumococci were obtained in 10 cases, Type II in 5 cases, Type 
III in 3 cases, and Type XVIII in 1 case. x  Felton's bivalent (Types I  and  II) 
concentrated antibody solution was used in the treatment of 5 Type I and 3 Type 
II cases.  3 patients were treated with sera prepared by the Felton method from 
normal horse serum (Case 7) and from antimeningococcus serum (Cases  16 and 17). 
In 1 instance (Case 18)there was an opportunity to study fluid both before and 
after  serum  treatment. ~  All of the  therapeutic  sera  were  administered  intra- 
venously. 
The fluids were secured,  under aseptic precautions, by thoracentesis, choosing 
a point in the area of maximum percussion dulness.  A solution of 1 or 2 per cent 
novocaine was injected through a  24  gauge needle  to anesthetize  the skin and 
underlying tissues, including the parietal pleura, a total of 1 or 2 cc. being used in 
the process.  The fluid was then aspirated into a dry syringe through an 18 or 20 
1 All of the sera used in typing were obtained through the courtesyof Dr. William 
H. Park, Laboratories of the New York City Department of Health. 
2 The therapeutic sera were prepared and supplied through the courtesy of Dr. 
L. D. Felton, Department of Preventive Medicine and Hygiene, Harvard Medical 
School, and of Dr. Benjamin White, Antitoxin and Vaccine Laboratory, Massa- 
chnsetts State Department of Public Health. 172  PNELr~ONIC PLEURAL FLUIDS 
gauge needle.  Some of the fresh  fluid was then inoculated  into rabbit's blood 
broth and streaked on an agar plate containing  rabbit's blood, and 1 cc.  was in- 
jected into a mouse for routine pneumococcus typing.  The remainder was allowed 
to clot, then centrifuged  and the supernatant fluid stored in the ice box for later 
studies.  In most instances, venous blood for culture and for the determination  of 
circulating antibodies was obtained at about the time of the thoracic puncture. 
The hydrogen ion concentration was obtained with the use of indicators by com- 
parison with standard buffer solutions as recommended by Clark (25). 
Antibody Determinations.--The protection titer  of the fluids  was  determined 
by  a  mouse  technique  s~milar to  that  employed  by  Dochez  (26).  Agglu- 
tinins for pneumocoeci were shown by a technique  similar  to that employed by 
Tillett and Francis (27).  The meningoeoccic antigen used in 2 instances  was a 
formalized saline suspension of 1 of the strains employed in the preparation of the 
therapeutic sera.  The agglutinations  of this antigen were carried out by heating at 
55°C. for 12 to 18 hours.  Precipitinogens  were demonstrated by adding 0.2 co. of 
undiluted antipneumococcic typing sera 3 to equal amounts of the fluids, incubating 
for 2 hours at 37°C. and reading after storage overnight in an ice box.  Precipitins 
were  demonstrated  in  a  similar  manner using  1:1000  solutions  of the  specific 
polysaccharides  of Types I, II, and III pneumococci.  No attempt was made to 
obtain the exact  titer  of preeipitin  and precipitinogen.  The presence  of horse 
serum was detected in a similar manner by the precipitin  reaction except that the 
anti-horse rabbit serum 4 was used in 1 :  2 dilution and varying dilutions of the fluids 
and  sera  from the  patients were  used  in order to  obtain  quantitative  results. 
The anti-horse  rabbit serum used in this manner gave a precipitate  with normal 
horse serum up to a dilution of 1 : 80,000 of the latter. 
Results of Immunological  Studies 
The results of the various bacteriological and immunological studies 
of the pleural fluids and of the corresponding blood sera are given in 
Table  I.  Cultures  in rabbit's blood broth and on blood agar plates, 
as  well  as  mouse inoculations,  were  negative in  the  controls and  in 
18 of the pneumonic fluids obtained from 14 patients.  The remaining 
13  fluids  were  infected.  Pneumococci corresponding in  type to  the 
causative  agent  of  the  pneumonia  were  recovered  from  11  fluids, 
whereas hemolytic streptococci were present as secondary invaders in 
2 fluids from Case 15. 
From a study of Table I it wiU be seen that neither antigen nor anti- 
s Obtained  through the courtesy of Dr. Augustus  B. Wadsworth,  Laboratories 
of the New York State Department of Health. 
4 Prepared by Dr. T. F. Hunnicut. MAXWELL  FINLAND  173 
Explanation  of Table ~r 
Day of puncture and Day of crisis.  The figures represent the number of days 
after the onset of the pneumonia. 
Days under the heading Serum treatment represents all the days  during which 
treatment was given (the figures are inclusive). 
Horse serum and Agglutlnins.  The figures represent the weakest dilution of 
fluid or blood sera in which reactions were observed. 
Protection.  The titer is represented thus: 
+  =  protection against 10 or 100 lethal doses. 
+  +  =  protection against 1000 or 10,000 lethal doses. 
+  +  +  =  protection against 100,000 or 1,000,000  lethal doses. 
+  +  +  +  =  protection against 10,000,000  or more lethal doses. 
Precipitins and Preci~nogens. +, +  +, etc., represent the intensityof the reac- 
tion, from +, indicating a definite but slight precipitate with a cloudy supernatant 
fluid to +  +  +  +, indicating a clear supematant fluid and a heavy sediment. 
D.  =  died. 
P.M.  -- post mortem. 
Neg.  -- negative. 
--  =  not done. 
Pn.  ffi pneumococcus. 
A bbreviations 
Str. k.  = Streptococcus kemolyticus. 
Mening.  =  meningococcus. 
I  =  Pneumococcus Type I. 
II  =  Pneumococcus Type II. 
III  =  Pneumococcus Type III. TAB
Bacteriological and Immunological Studies of Pneumo
Pleural fluids
Concentration  of anti
Case  Pneu-  Day of  Day  of  Serum  HMosCnetaiof__
No.  mococ-  risis  Punc-  treatment  PH  Mouse
cus  type  ture  Culture  inocula-  Protection  Agglutinins
tion  Horse
serum  I 
Sterile
I.  Patients  receiving
cc.  days
3  III  10  3  0  - Neg.  Neg.  - - - - 0  0  0
12  I  5  4  0  - 8.0  Neg.  Neg.  - - - - 0  0  0
2  I  5  5  0  - 7.2  Neg.  Neg.  0  - +  0  0  2
9  I  10  10  0  - 8.0  Neg.  Neg.  - +  0  - 0  0  0
18  7.7  Neg.  Neg.  - ++  0  - 8  0  0  +
5  III  7  21  0  - 7.6  Neg.  Neg.  - 0  +++++  0  2  8
II.  Patients treated  with Felton's  con
6  II  4  4  322  2-4  7.8  Neg.  Neg.  400  - - - 16  32  0  +
14  I  3  10  70  2  8.0  Neg.  Neg.  100  +  +  - 0  0  0
11  II  6  9  346  2-5  7.6  Neg.  Neg.  50  ++  +  - 0  0  0
4  I  5  33  174  4-5  - Neg.  Neg.  - - ++  -0  0  0
15  II  - 9  264  3-5  8.0  Neg.  Neg.  200  - ++  - 16  32  0  +
13  8.0  Neg.  Neg.  100  0  0  - 2  8  0  +
10  I  18  14  183  13-14  8.2  Neg.  Neg.  400  +++-  +  0  0  8  0
17  8.0  Neg.  Neg.  400  +  ++-  0  8  32  0
III. Patients  treated
7  I  - 15  53  2  8.0  Neg.  Neg.  50  -++  0  0  2  0  0  0
16  XVIII  7  5  127  2-3  7.7  Neg.  Neg.  200  - - - Mening.  1:50  -
7  8.0  Neg.  Neg.  so50  - - - Mening.  1:50  -
17  II  3  4  75  2  7.8  Neg.  Neg.  100  - - - 01  0  I  0  0
Infected
I.  Patients  receiving
18  I  D.4  2  0  - 7.4  Pn.I  Pn.I  0  00  0  0  0
13  II  D.8  7  o  - 7.8  Pn.  I  PI.  I  0  0  0  0  0
13  Ill  .4  Si.  III  I. k  III  0  0  0 
1  II  D.18  17  0  - 6.4  Pn. II  Pn.I  - - - 0  0  0  0
8  I  - 12  0  - 5.6  Pn. I  Pn. I  - 0  - - 0  0  0  0
15  5.6  Pn. I  Pn. I  -0  0  - - 0  0  0  0
II.  Patients  treated  with  Felton's  con
18  I  D.4  P.M.  305  3-4  7.2  Pn. I  Pn.I  200  0  0  00  8  0  0
i5  II  - 22  264  3-5  7,2  Sir.  . Sir.  . 10  0  +  0  0  4  0  +
23  5.4  Sitr. h.  Sirh.  100  0  0  0  0  2  0  0
19  I  - 10  140  4-5  7.2  Pn.  I  Pn.  400  0  ++  - 0  8  0  0
13  7.0  Pn. I  Pn. I  400  0  +  - 0  8  0  0
14  6.3  Pn I  Pn. I  200  0  ++  - 0  4  0  0
19  6.3  Pn. I  Pn. I  200  0-++  0  0  2  0  0
III.  Patients  treated
7  iI  - 26  153  2  6.4  Pn.I  Pn.I  - - [  - I-I-I  0  0  [
Non-Pneum
20  Rheumatic  pleurisy  7.8  Neg.  Neg.  - 0  0  0  0  0  0  0
21  Cardiac  decompensation  7.8  - I  - 0  0  0  0
22  Pleurisy  with effusion  8.2  Neg.  Neg.  0  0  0  0  0
7.8  Neg.  Neg.  - - - 0  0  0  0  0
*  This patient received  skin  tests with  the specific polysaccharides  of Types I, II, and  III pneumococci.
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Blood serum
en and antibodi¢i  Concentration of antigen and antibodies
Blood
Precipitins  Precipitinogens  culture  Protection  Agglutinins  Precipitins
_________________________  Horse  Bl  o  od  serum
Prcddlioa  cuIII  re  serum  I  I  III  I  n
I Ii  (mjI  II  II  I  II  InII  III  I  I
Fluids
no  serum treatment
o  0  0  0  0  0  Neg.  - 0  0  0  0  0  0  0  0  0
o  0  0  0  0  0  Neg.  - -
o  +  - - - Neg.  - +  0  +  0  0  8  0  0  0
o  0  0  0  0+  0  Neg.  - ++  0  - 8  0  0  ++  0  0
o  0  0  0  0  0  Neg.  - ++  0  0  8  0  0  ++  0  0
o  ++++  0  0  o0  Neg.  - +  +++++  0  64  64  0  ++  ++
centrated  antibodies (Types  I and II)
++ +'++0  0  0  0  Neg.  1600  ++±  ++  - 16  32  4  .j-+.++  0
+  0  0  0  0  0  Neg.  - -
0  0  0  0  0  0  Neg.  - -
o  0  - - - Neg.  - +  ++  0  0  0  0  0  0
+  +  0  0  0  0  Neg.  1600  0  0
++  +  0  0  0  0  Neg.  1600  0  +  4  8  0  +  +-  0
0  0  0  0  0  0  Pn.I  1600  ++  ++  32  64  0  ++  +++  0
+  4-  0  0  0  0  Neg.  1600  +++  . +  . 16  32  0  ++  ++  0 -e  a a a  Neg.  160  +f+  f+  6 32  a  o  ++t  o
with  non-specific sera
0  0  0  0  0  Neg.  - +  4  0 0  - - -
- - - - - Neg.  800  - Mening.  1:1600  - -
- - - - - Neg.  800  Mening.  1:1600  - -
0  0  0  0  0  Neg.
Fluids
no serum  treatment
0  0+  +  0  0  Pn.I  - 0  0  0  0  0  0  0  0  0
0  0  0  0  +++  Pn. III
0  0  0  ++++  0
0  0..++  0  0
0  0o++++  0  0
centrated  antibodies  (Types  I and II)
0  0.++  0  0  Pn.I  400+ +++  ++  +  32  64  4  0  ++++ 0
+  +  0  0  0  0  Neg.  1600  0  - - 2  8  0  +  0  0
0  0  0  0  0  Neg.  800  - +  - 2  4  0  0  0  0
0  0 ++++  0  0  Neg.  400++++++.  8  4  0  0  0  0
0  0  +.++.+  0  0  Neg.  400  +.  +  - 2  4  0  0  0  0
0  0  ++++  0  0  Neg.
0  0  ++++  0  0  Neg.
with non-specific  sera
o  oI0  o l++++o  o  eg. 
onic Fluids
0  0  0  0  0  Neg.  - 0  0  0  0  0  0  0  0
0  0  0  0  0
0  0  0  0  0  Neg.  - - - 0  0  0  0  0  0  0
0  0  0  0  0  - - 0  0  0  0  0  0  0
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bodies could be demonstrated by precipitin tests in the sterile pneu- 
monic fluids during the acute stage of the disease when no specific 
sera had previously been given.  At this time antibodies could not be 
found in the blood of these patients.  At the time of crisis or later 
antibodies corresponding to those found in the blood sera were demon- 
strated in the sterile fluids of the untreated cases.  Sterile fluids ob- 
tained from patients who had received therapeutic sera were shown to 
contain horse  serum and  antibodies  corresponding to  those of the 
therapeutic sera.  Similar antibodies were found in the blood of these 
patients. 
Fluids infected with pneumococci always showed homologous soluble 
specific substance, as demonstrated by the specific precipitate with the 
homologous antipneumococcic serum.  In the cases that were given 
antisera containing the homologous and heterologous antibodies, horse 
serum and heterologous antibodies could be demonstrated along with 
homologous  antigen.  The  blood,  however,  contained  both  homo- 
logous  and  heterologous antibodies.  When infection was  due to  a 
secondary invader  (Case  15),  homologous pneumococcic antibodies 
could be demonstrated in the pleural fluid.  Occasionally no antibodies 
could be demonstrated in fluid when the serum showed a good titer. 
In one instance (Case 7), when a fluid, sterile early in convalescence, 
later became infected, actively acquired antibodies for the homologous 
type were demonstrated on the former occasion and antigen, but no 
antibodies, on the latter.  The tests on the control fluids in the non- 
pneumonic patients were entirely negative. 
The quantitative relationships between the antibodies in the fluids 
and those in the corresponding sera were not always constant.  The pro- 
tective titer is diificult to compare, but in half of the instances in which 
protection  for  the  same  organisms  was  demonstrated  in  both  the 
serum and fluid the titer was found to be the same.  In the remaining 
instances, with one exception in which more protection was found in 
the fluid, the serum protected in only 1 or 2 dilutions higher (against 
10 to 100 times the number of lethal doses of pneumococci) than the 
corresponding  fluid. 
The ratio of the agglutinin titers in the fluids to those in the sera 
varied from 2:1 to 1 : 32.  In 19 instances where corresponding agglu- 
tiuins were demonstrated in both fluid and serum, the ratio of the titer MAXWELL  FINLAND  177 
in the fluid to that in the sera was 1: 1 or 1: 2 in 10 instances; in 4 others, 
it was 1:4 or 1 : 8; in 3, it was 1 : 32; and, in the remaining 2, it was 2:1. 
The titer of horse serum, using the same anti-horse rabbit  serum 
throughout, showed similar relations between the fluid and blood.  Of 
12 instances where a comparison was possible the ratio of the titer in 
the fluid to that in the serum was 1:1 in 2 instances; 1: 4 in 5; 1: 8 or 
1:16 in 4; and 1:160 in a single instance. 
DISCUSSION 
Numerous  studies  have  been  made on  absorption  of  fluids, fats, 
particulate matter, and bacteria from the pleural cavity (28).  Little 
mention, however, has been made of the passage of materials from the 
circulation into the pleural cavity.  Furthermore, as far as could be 
ascertained, the only direct reference to the presence of specific anti- 
bodies in pneumonic pleural fluids are those referred to above (9, 10, 
13).  It has here been demonstrated that antibodies actively produced 
by the patient or passively introduced into the blood stream appear in 
the pleuritic effusion of patients with lobar pneumonia, whether such 
effusions are sterile or infected.  As a rule, the concentration of horse 
serum and of antibodies in the fluids has been either the same or, more 
commonly, lower than in blood serum.  This is not in accord with the 
findings of Couraux (29) and Paraskevopoulos (30), who each found 
more ~ntibodies against the tubercle bacillus in pleural fluid than in 
the blood, but agrees with the finding in Pepper's case (15) where the 
ratio of the titer of typhoid agglutinins in the fluid to that in the serum 
was 4: 5.  Pinner and Moerke (17) found that the blood averaged 27 
per cent more globulin than the tuberculous pleural effusions wMch 
they studied, although there were individual instances where the fluid 
contained more globulin than the serum.  These findings are signifi- 
cant since the intimate association of antibodies with serum globulin 
is well recognized. 
These observations cannot, of course, be interpreted as indicating 
that the normal pleura is permeable to immune bodies.  That injury 
to the pleura through the inflammatory processes in the lung renders it 
more permeable is very likely in view of the findings of Flexner and his 
coworkers (21) in relation to the passage of immune substances into the 
cerebrospinal fluid. 178  PNEUMONIC  PLEURAL  FLUIDS 
It appears that the presence of antibodies in the effusion does not 
necessarily prevent its subsequent infection by the homologous organ- 
isms.  When  such  infection  does  occur,  soluble  specific  substance 
appears in the fluid and the homologous antibody can no longer be 
demonstrated; but such horse serum and heterologous antibodies as 
may have been introduced can still be found.  This agrees with the 
findings of Cole (11) already mentioned. 
SUMMARY  AND  CONCLUSIONS 
Pleuritic  exudates  from  patients  with  lobar  pneumonia  may be 
sterile or infected.  Sterile fluids, at or about the time of crisis, contain 
actively acquired antibodies similar to those in the blood serum.  In- 
fected fluids do not contain such antibodies, presumably because of the 
presence  in  them  of  large  amounts  of  soluble  specific  substance. 
Sterile fluids from patients treated with immune sera have both horse 
serum and antibodies similar to those injected.  Infected fluids from 
serum-treated cases contain horse serum and such heterologous anti- 
bodies as were contained in the therapeutic sera together with homo- 
logous soluble specific substance.  The concentration of horse serum 
and antibodies in pneumonic fluids is usually the same or somewhat 
less than that of the corresponding blood sera. 
The  author  is  grateful  to  Miss  Beatrice  Tyndall  for  technical 
assistance. 
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